V62A (p.Val62Ala) variant of AGTR1 (Type-1 angiotensin II receptor)

V62A (p.Val62Ala) in AGTR1 (Type-1 angiotensin II receptor) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.51 / 1. The record also includes population frequency data and structural context.

V62A (p.Val62Ala) variant details